<SEC-DOCUMENT>0001641172-25-024661.txt : 20250818
<SEC-HEADER>0001641172-25-024661.hdr.sgml : 20250818
<ACCEPTANCE-DATETIME>20250818172043
ACCESSION NUMBER:		0001641172-25-024661
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250812
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250818
DATE AS OF CHANGE:		20250818

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALT5 Sigma Corp
		CENTRAL INDEX KEY:			0000862861
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				411454591
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19621
		FILM NUMBER:		251228889

	BUSINESS ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119
		BUSINESS PHONE:		702-997-5968

	MAIL ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JanOne Inc.
		DATE OF NAME CHANGE:	20190912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	APPLIANCE RECYCLING CENTERS OF AMERICA INC /MN
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ALTS="http://alt5sigma.com/20250812">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_ALTS_alt5sigma.com_20250812 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250812_20250812 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0000862861 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000004" name="dei:EntityCentralIndexKey">0000862861</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="alts-20250812.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-12</xbrli:startDate>
        <xbrli:endDate>2025-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20250812__20250812_zdvGYhbOMPRk"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported) <b><span id="xdx_906_edei--DocumentPeriodEndDate_c20250812__20250812_zmg6pBu4G3O1"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 12, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_905_edei--EntityRegistrantName_c20250812__20250812_zMEpf3BGMZb6" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000011" name="dei:EntityRegistrantName">ALT5
SIGMA CORPORATION</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250812__20250812_zYQOwQmlvzL4"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20250812__20250812_zEMfJOQ0xG4a"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000013" name="dei:EntityFileNumber">000-19621</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20250812__20250812_zDZq1V00g5il"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000014" name="dei:EntityTaxIdentificationNumber">41-1454591</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction<br/>
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250812__20250812_zJq26hOPPkj1"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000015" name="dei:EntityAddressAddressLine1">325
    E. Warm Spring Road</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20250812__20250812_zhmk0HSErTSe"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 102</ix:nonNumeric></span><br/>
    <span id="xdx_90C_edei--EntityAddressCityOrTown_c20250812__20250812_zS9N8Jo7fW25"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000017" name="dei:EntityAddressCityOrTown">Las Vegas</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250812__20250812_ze9ND5Ca21Rd"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000018" name="dei:EntityAddressStateOrProvince">NV</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressPostalZipCode_c20250812__20250812_zmAxD4fvWL7f"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000019" name="dei:EntityAddressPostalZipCode">89119</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code <span id="xdx_90A_edei--CityAreaCode_c20250812__20250812_zJNdZ7PhSbz7"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000020" name="dei:CityAreaCode">(702)</ix:nonNumeric></span> <span id="xdx_905_edei--LocalPhoneNumber_c20250812__20250812_zxh9fFURLqLk"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000021" name="dei:LocalPhoneNumber">997-5968</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--WrittenCommunications_c20250812__20250812_zRo5nkPSSiD8"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20250812__20250812_z5UNpRbWnWV6"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250812__20250812_z1XzkV2Ka6T9"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250812__20250812_zAY951ZXRDjl"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20250812__20250812_zhtzGDuWGAR1"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000026" name="dei:Security12bTitle">Common
    stock (par value $0.001 per share)</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20250812__20250812_zxw12PjJT1T7"><ix:nonNumeric contextRef="AsOf2025-08-12" id="Fact000027" name="dei:TradingSymbol">ALTS</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20250812__20250812_zpq1gB7fQMU4"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20250812__20250812_zssvzzWnZrvg"><ix:nonNumeric contextRef="AsOf2025-08-12" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Registered
Direct Offering </span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2025, ALT5 Sigma Corporation (the &#8220;Company&#8221;) consummated the previously announced transactions whereby the Company
entered into securities purchase agreements (the &#8220;Registered Offering Purchase Agreements&#8221;) with certain institutional investors
pursuant to which the Company agreed to issue to the Purchasers (as defined therein), in a registered direct offering (the &#8220;Registered
Offering&#8221;), an aggregate of 100,000,000 shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;),
at a purchase price of $7.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use up to $10,000,000 of the net proceeds from the Registered Offering to settle existing litigation, pay existing
debt, and fund the Company&#8217;s existing business operations, and the balance of the net proceeds will be used to fund the acquisition
of $WLFI tokens from World Liberty Financial, Inc. (the &#8220;Lead Investor&#8221;), pursuant to a Token Purchase Agreement, and the
establishment of the Company&#8217;s cryptocurrency treasury operations. The shares of Common Stock issued in the Registered Offering
were</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
pursuant to a prospectus supplement, which was filed with the Securities and Exchange Commission on August 11, 2025, in connection with
a takedown from the Company&#8217;s shelf registration statement on Form S-3, as amended, (File No. 333-289176), which was declared effective
by the Securities and Exchange Commission on August 8, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Private
Placement Offering</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
on, August 12, 2025, the Company consummated the previously announced transaction whereby the Company
entered into a securities purchase agreement</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&#8220;Private Placement Purchase Agreement&#8221; and, together with the Registered Offering Purchase Agreements, the &#8220;Purchase
Agreements&#8221;), with the Lead Investor, pursuant to which the Company received $750 million of $WLFI tokens based
on an exchange rate of $0.20 per token</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and issued
the Lead Investor, in a concurrent private placement (the &#8220;Private Placement&#8221; and together with the Registered Offering,
the &#8220;Offerings&#8221;), 1,000,000 shares of Common Stock at a purchase price of $7.50 per share (the &#8220;PIPE Shares&#8221;),
and pre-funded warrants (the &#8220;PIPE Pre-Funded Warrants&#8221;) to purchase up to 99,000,000 shares of Common Stock (the
&#8220;PIPE Pre-Funded Warrant Shares&#8221;)</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
a purchase price of $7.499 per PIPE Pre-Funded Warrant. Each of the PIPE Pre-Funded Warrants is exercisable for one share of Common Stock
at an exercise price of $0.001 per PIPE Pre-Funded Warrant Share.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PIPE Pre-Funded Warrants are not exercisable until the Company has obtained stockholder</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval to: (i) allow,
for the purpose of complying with Nasdaq rules,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
issuance of shares underlying the PIPE Pre-Funded Warrant in excess of 19.99% of the shares of common stock outstanding immediately prior
to the execution of the Purchase Agreements</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&#8220;Exchange Cap&#8221;) and (ii) filed an amendment to its Articles of Incorporation to increase the number of authorized shares
of common stock (the &#8220;Amendment&#8221;). Following the effectiveness of the Amendment, the PIPE Pre-Funded Warrants may be exercised
at any time until all of the PIPE Pre-Funded Warrants are exercised in full, subject to certain beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agreed to hold an annual or special meeting of stockholders on or prior to September 30, 2025 and to file a Preliminary Proxy
Statement with the Commission within</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date that is twenty (20) business days following the closing date for the purpose of obtaining the stockholder approval of</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exchange Cap and the Amendment (the &#8220;Stockholder
Approval&#8221;), with the recommendation of the Company&#8217;s Board of Directors that the proposal to approve the Amendment. If the
Company does not obtain Stockholder Approval at the first meeting, the Company is obligated to call a meeting every ninety (90) days
thereafter to seek Stockholder Approval until the date on which Stockholder Approval is obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Private Placement Purchase Agreement, the Lead Investor was issued Common Stock Purchase Warrants (the &#8220;Lead Investor Warrants&#8221;)
to purchase up to 10% of the number of shares of common stock or pre-funded warrants
sold in the Offerings,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
20 million shares of common stock. The Lead Investor Warrants are exercisable (i) 8,000,000 shares of Common Stock at an exercise price
of $7.50 per share of Common Stock; (ii) 4,000,000</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of Common Stock at an exercise price of $8.25 per share of Common Stock; (iii) 4,000,000</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock at an exercise price of $9.00 per share
of Common Stock; and (iv) 4,000,000</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of Common Stock at an exercise price of $9.75 per share of Common Stock, subject to adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance and sale of the PIPE Shares, the PIPE Pre-Funded Warrants, the Lead Investor Warrants and the Lead Investor Shares (collectively,</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the &#8220;PIPE Securities&#8221;) were</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not registered under the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), or any state securities laws. The PIPE Securities were</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued in reliance on the exemption from registration provided
by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder for transactions not involving a public offering.
Pursuant to the terms of the Registration Rights Agreement (as defined herein), the Company is required to file a registration statement
providing for the resale of the PIPE Securities within 15 days of the closing of the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registered Offering resulted in gross proceeds of $750 million and the Private Placement resulted in the receipt of $750
million of $WLFI tokens, in each case before deducting placement agent commissions and other offering expenses.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreements, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed
issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement
thereto, for a period of thirty (30) days after the initial registration statement has been declared effective, subject to certain customary
exceptions, including the use of the Sales Agreement (as defined herein), without the consent of the Purchasers, the Lead Investor,
and the Placement Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Placement
Agency Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a Placement Agency Agreement with A.G.P./Alliance Global Partners (the &#8220;Placement Agent&#8221;), dated August
11, 2025, pursuant to which the Placement Agent acted as the exclusive placement agent for the Company in connection with the
Registered Offering (the &#8220;RD Placement Agency Agreement). Pursuant to the RD Placement Agency Agreement, the Company paid
the Placement Agent a cash fee of 3% of the gross proceeds from the Registered Offering and granted to the Placement Agent (or
its designees) warrants to purchase that number of shares of Common Stock equal to 3% of the securities sold in the Registered Offering,
which will be exercisable beginning 180 days following the closing date, and have an initial exercise price per share of Common Stock
of $8.25 (the &#8220;Placement Agent Warrants&#8221;). In addition, the Company reimbursed the Placement Agent up to $475,000
of its fees and expenses, and up to $10,000 in non-accountable expenses, in connection with the Registered Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also entered into a Placement Agency Agreement with the Placement Agent, dated August 11, 2025, pursuant to which the Placement
Agent acted as the exclusive placement agent for the Company in connection with the Private Placement (the &#8220;PIPE Placement
Agency Agreement). Pursuant to the PIPE Placement Agency Agreement, the Company paid the Placement Agent (or its designees) a
cash fee of (i) $6,500,000 for all tokens paid for the securities sold in the Private Placement in excess of $500,000,000 and (ii) 3%
of the gross proceeds of cash paid for the securities sold in the Private Placement Offering by the Placement Agent, and granted
to the Placement Agent, Placement Agent Warrants equal to 3% of the securities sold in the Private Placement, which will be exercisable
beginning 180 days following the pricing of the offering, and have an initial exercise price per share of Common Stock of $8.25.
In addition, the Company reimbursed the Placement Agent up to $475,000 of its fees and expenses, and up to $10,000 in non-accountable
expenses, in connection with the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Placement Agent Warrants and the shares of Common Stock underlying the Placement Agent Warrants (the &#8220;Placement
Agent Warrant Shares&#8221;) was</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
 registered under the Securities Act or any state securities laws. The Placement Agent Warrant Shares were</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued in reliance on the exemption from registration provided
by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder for transactions not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agency Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company, other obligations of the parties, and termination provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Registration
Rights Agreement</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2025, the Company and the Lead Investor entered into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;),
pursuant to which the Company agreed to file a registration statement (the &#8220;Resale Registration Statement&#8221;), providing for
the resale of the PIPE Securities within 15 days of the closing of the Private Placement, to have such registration statement declared
effective with 30 days of the filing date (or 60 days, if the Securities and Exchange Commission conducts a full review) (the date of
such effectiveness, the &#8220;Effective Date&#8221;), and to maintain the effectiveness of such registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b><i><span style="text-decoration: underline">Asset Management Agreement</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="margin: 0pt 0pt 0pt 0; text-align: justify">Further, on August 11, 2025 (the &#8220;AMA Commencement Date&#8221;), the Company
entered into an Asset Management Agreement (the &#8220;Asset Management Agreement&#8221;) with an
asset manager named therein (the &#8220;Asset Manager&#8221;), pursuant to which the Asset Manager shall provide discretionary
investment management services with respect to the Company&#8217;s cryptocurrency treasury. The term of the Asset Management Agreement
is for thirty (30) days renewable upon the mutual consent of the parties. The Asset Manager will receive a nominal fee as compensation
for its services under the Asset Management Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Lock-Up
Agreements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreements, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed
issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement
thereto, for a period of 30 days after the Effective Date, subject to certain customary exceptions, including the use of the Sales
Agreement (as defined herein), without the consent of the Purchasers, the Lead Investor and the Placement Agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, each of the Company&#8217;s directors and executive officers are subject to a lock-up agreement, which prohibits
them from offering for sale, pledging, announcing the intention to sell, selling, contracting to sell, granting any option, right or
warrant to purchase, or otherwise transferring or disposing of 50% of their shares of Common Stock or any securities convertible into
or exercisable or exchangeable for shares of Common Stock for a period of 90 days following the Effective Date and the remaining
50% upon the later of ninety (90) days after the Effective Date or the effective date of the Stockholder Approval. The lock-up agreements
do not prohibit our directors and executive officers  from transferring shares of our common stock for bona
fide estate or tax planning purposes, subject to certain requirements, including that the transferee be subject to the same lock-up terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Placement Agent Warrants, the PIPE Pre-Funded Warrants, the Registered Offering Purchase Agreement, the
Lead Investor Warrant,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Private Placement Purchase
Agreement, the RD Placement Agency Agreement, the PIPE Placement Agency Agreement, the Registration Rights Agreement, and the Lock-Up
Agreements do not purport to be complete descriptions thereof and are qualified in their entirety by reference to the full text of such
documents or the forms of such documents, copies of which are attached hereto as Exhibits 4.1, 4.2, 4.3, 4.6,</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1, 10.2, 10.3, 10.4, 10.5, and 10.6, respectively. The representations,
warranties, and covenants made by the Company in any agreement that is filed as an exhibit hereto were made solely for the benefit of
the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreement. In addition,
the assertions embodied in any representations, warranties, and covenants contained in such agreements may be subject to qualifications
with respect to knowledge and materiality different from those applicable to securityholders generally. Moreover, such representations,
warranties, or covenants were accurate only as of the date when made, except where expressly stated otherwise. Accordingly, such representations,
warranties, and covenants should not be relied on as accurately representing the current state of the Company&#8217;s affairs at any
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal opinion of Lucosky Brookman LLP relating to the legality of the issuance and sale of the securities in the Registered Offering
is attached hereto as Exhibit 5.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information under Item 1.01 of this Current Report on Form 8-K related to the Placement Shares, the RD Pre-Funded Warrant Shares, the
PIPE Securities, the Placement Agent Warrants, and the Placement Agent Warrant Shares is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>Item 5.02 Departure of Directors
or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Chief Financial Officer Resignation</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Effective August 12, 2025, Mr. Virland Johnson
resigned as the Chief Financial Officer of the Company. Mr. Johnson&#8217;s resignation was not due to any disagreement with the Company
on any matter relating to the Company&#8217;s operations, policies or practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span style="text-decoration: underline">Chief Financial Officer Appointment</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Concurrent with the CFO Resignation,
the Company has appointed Mr. Jonathan Hugh as the Company&#8217;s Chief Financial Officer, effective August 13, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Mr. Jonathan Hugh, age 55, brings over 25 years of senior finance and commercial leadership experience in Digital Assets, Technology, Energy and Commodities, working
with both public and private companies from large-cap multinationals to agile high-growth ventures. From June, 2021 to June, 2023,&#160;Mr.
Hugh served as the Chief Financial Officer of leading digital asset firm, GSR International Ltd, a global market maker. From
August 2023 to February 2025, Mr. Hugh, served as the Chief Financial Officer of Zodia Custody Limited, an institutional digital assets custodian.
Mr. Hugh is a member of the Institute of Chartered Accountants of England and Wales and holds an MA in Law from Cambridge University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">There are no arrangements or understandings
between Mr. Hugh and any other persons, pursuant to which Mr. Hugh was selected as an officer of the Company, Mr. Hugh has no family relationships
with any of the Company&#8217;s directors or executive officers, and Mr. Hugh is not a party to and does not have any direct or indirect
material interest in any transaction requiring disclosure under Item 404(a) of&#160;Regulation S-K&#160;under the&#160;Securities
Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;8.01.
Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2025, the Company issued a press release announcing the consummation of the Offerings. The press release is attached as Exhibit
99.1 to this Current Report on Form 8-K and incorporated into this Item 8.01 by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; vertical-align: bottom; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of PIPE Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex4-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Certification of Stock Designation of Series Q Convertible Preferred Stock</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex4-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Certification of Stock Designation of Series B Preferred Stock</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">4.5*<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><p style="margin: 0pt 0pt 0pt 0"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex4-5.htm" style="-sec-extract: exhibit">Amended Certification of Stock Designation of Series I Convertible Preferred Stock</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">4.6**</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="ex4-6.htm">Lead Investor Common Stock Warrants</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Lucosky Brookman LLP</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex5-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Lucosky Brookman LLP (related to At the Market Offering)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registered Offering Securities Purchase Agreement, dated as of August 11, 2025, between ALT5 Sigma Corporation and each Purchaser (as defined therein)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Private Placement Securities Purchase Agreement, dated as of August 11, 2025, between ALT5 Sigma Corporation and each Purchaser (as defined therein)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RD Placement Agency Agreement, dated August 11, 2025, between ALT5 Sigma Corporation and A.G.P./Alliance Global Partners</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Placement Agency Agreement, dated August 11, 2025, between ALT5 Sigma Corporation and A.G.P./Alliance Global Partners</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement, dated as of August 11, 2025, between ALT5 Sigma Corporation and each Purchaser (as defined therein)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex10-6.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/862861/000164117225022905/ex5-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Lucosky Brookman LLP (included in Exhibit 5.2)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">99.1**</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm">Press Release dated August 12, 2025</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">* Previously filed.</p>

<p style="margin: 0pt 0pt 0pt 0">** Filed herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALT5
    SIGMA CORPORATION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 18, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 3%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 47%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Peter Tassiopoulos</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Tassiopoulos</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Section: Cover/ROC; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbQdTGR3OnSIU2SIeFtclOLWjLT+PZJvad0QQyAk53w5QsSioKVpkOE4r0rYY9s12iNUeEZGe8LgyFfrDMKs8GKcZ219v/7AnAKDgZmMlA733nk3DusM5HSs5DhJQaZZqmC2EdFXz8meTY3WG92AtjXsmDo26DW/hg97/SRL7atPOiA7QzYDNZKD/IZEqgS2dNcP4quDssxFFPcViYLp1gXX4unRfklYNNiGODfQ/44+wilKTA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;<U>SECURITIES ACT</U>&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>
 PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALT5
SIGMA CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 99,000,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: August 12, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, World Liberty Financial, Inc. or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the completion of the Authorized Share Increase (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until
this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;), to subscribe for and purchase from ALT5 Sigma Corporation,
Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 99,000,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated August 11, 2025, among the Company and the Holder.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or DocuSign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of
this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price
under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per Warrant Share under this Warrant shall be
$0.001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Reserved</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit and Withdrawal at Custodian (&ldquo;<U>DWAC</U>&rdquo;) service if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register
in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading Day after the
delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company
and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery
of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each
Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The
Company agrees to maintain a transfer agent that is a participant in the FAST Program so long as this Warrant remains outstanding and
exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number
of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 noon
(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement,
the Company agrees to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time)
on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided
that payment of the aggregate Exercise Price is received by such Warrant Share Delivery Date. For the purposes of this Section 2(d)(1),
&ldquo;VWAP&rdquo; shall mean, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported
by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is
a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock
are then reported on OTCID (or an organization or agency succeeding to the functions of OTC Markets Group Inc. of reporting prices),
the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common
Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Securities then
outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely
due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Warrant Shares so purchased exceeds (y) the amount obtained by
multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at
issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the
Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Exhibit B duly executed by the Holder and the
Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates, (ii) any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons whose beneficial
ownership of the shares of Common Stock would or could be aggregated with the Holder&rsquo;s for purposes of Section 13(d) (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and
Attribution Parties shall include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act. To the extent that the limitation contained in this Section 2(e) applies, the submission of a
Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon sixty (60) written
notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the
Beneficial Ownership Limitation in no event exceeds 19.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such
notice is delivered to the Company. If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding
shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number
of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the beneficial ownership
of Holder together with the Attribution Parties, as determined pursuant to this Section 2(e), to exceed the Beneficial Ownership Limitation,
the Holder shall then notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (such
notice, the &ldquo;Reduction Notice&rdquo;). Such issuance shall not be deemed to have occurred until the Holder provides the Reduction
Notice (or a notice that no reduction is needed) to the Company. In the event that the issuance of Common Stock to the Holder upon exercise
of this Warrant results in the Holder, together with the Attribution Parties, collectively being deemed to beneficially own, in the aggregate,
more than the Beneficial Ownership Limitation, the number of shares so issued by which the aggregate Beneficial Ownership of the Holder
and its Attribution Parties exceeds such limitation (the &ldquo;Excess Shares&rdquo;) shall be deemed null and void and shall be cancelled
ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares. As soon as
reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder
the exercise price paid by the Holder for the Excess Shares and the Holder shall return the Excess Shares to The provisions of this paragraph
shall not be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in">f)
Exchange Cap. Notwithstanding any other provision herein, the Company shall not be obligated to issue any shares of Common Stock upon
exercise of this Warrant if the issuance of such shares of Common Stock would exceed the Exchange Cap, as that term is defined herein,
if and to the extent applicable, except that such limitation shall not apply in the event that the Company (i) obtains the approval of
its stockholders as required by applicable rules and regulations of the Trading Market for issuances of Common Stock in excess of the
Exchange Cap and until completion of the Authorized Share Increase, or (ii) obtains a written opinion from outside counsel to the Company
that such approval is not required. Until such approval or written opinion is obtained, no Holder of this Warrant shall be issued, upon
exercise this Warrant, shares of Common Stock in an amount that, when added to all Securities issued to such Holder, is greater than
the product of (x) the Exchange Cap amount multiplied by (y) a fraction, the numerator of which is the number of Warrant Shares issuable
upon exercise to such Holder pursuant to this Warrant and the denominator of which is the aggregate amount of all the Warrant Shares
issuable upon exercise to the Holders of all Warrants issued under the Purchase Agreement (the &ldquo;Cap Allocation Amount&rdquo;).
In the event that the Holder shall sell or otherwise transfer any portion of this Warrant, the transferee shall be allocated a pro rata
portion of the Holder&rsquo;s Cap Allocation Amount. In the event that the Holder shall exercise all of this Warrant into a number of
shares of Common Stock that, in the aggregate, is less than the Holder&rsquo;s Cap Allocation Amount, then the difference between the
Holder&rsquo;s Cap Allocation Amount and the number of shares of Common Stock actually issued to such Holder shall be allocated to the
respective Cap Allocation Amounts of the Purchasers on a pro rata basis in proportion to the number of Warrant Shares issuable upon exercise
then held by the Purchasers. For the purposes of this Section 2(f), &ldquo;Exchange Cap&rdquo; shall mean the Trading Market&rsquo;s
limitation against Holder&rsquo;s acquisition of shares of Common Stock pursuant to the Purchase Agreement, to the extent that after
giving effect thereto, the aggregate number of shares of Common Stock that would be issued pursuant to the Purchase Agreement and the
Transactions contemplated thereby would exceed 19.99% of the number of shares of Common Stock issued and outstanding immediately prior
to the execution of the Agreement, which number of shares would be reduced, on a share-for-share basis, by the number of shares of Common
Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions contemplated
by this Agreement under applicable rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of Warrant Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (excluding a merger effected
solely to change the Company&rsquo;s name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the assets of
the Company and its Subsidiaries, taken as a whole, in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding shares of the aggregate voting power of all classes of equity of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of the aggregate voting power of all classes of equity of the Company (not including any shares of Common Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise
of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant) (the &ldquo;<U>Fundamental Transaction Rights</U>&rdquo;), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
Warrant Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to,
and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other
Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right
and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents
with the same effect as if such Successor Entity had been named as the Company herein; provided, however, that to the extent that the
Holder&rsquo;s right to participate in any such Fundamental Transaction Rights would result in the Holder and its Attribution Parties,
collectively beneficially owning in excess of the Beneficial Ownership Limitation of the Common Stock that would be issued and outstanding
following receipt of such Fundamental Transaction Rights (such excess amount of Common Stock, the &ldquo;Excess Fundamental Transaction
Rights&rdquo;), then the Holder shall not be entitled to participate in such Fundamental Transaction Rights to the extent of the Excess
Fundamental Transaction Rights (and shall not have the right to acquire such Excess Fundamental Transaction Rights). The Excess Fundamental
Transaction Rights shall be held in abeyance for the benefit of the Holder until such time or times as (1) its right to receive some
or all of the Excess Fundamental Transaction Rights would not result in the Holder and its Attribution Parties beneficially owning Common
Stock in excess of the Beneficial Ownership Limitation and (2) the Holder so certifies in writing to the Company and specifies the number
of shares of Common Stock it is able to receive without exceeding the Beneficial Ownership Limitation, at which time or times the Holder
shall be granted that portion of the Excess Fundamental Transaction Rights (and any Excess Fundamental Transaction Rights granted, issued
or sold on such initial Fundamental Transaction Rights or on any subsequent Fundamental Transaction Rights to be held similarly in abeyance)
to the same extent as if there had been no such limitation. For the avoidance of doubt, the Holder shall be entitled to the benefits
of the provisions of this Section 3(d) regardless of whether the Company has sufficient authorized shares of Common Stock for
the issuance of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
[Reserved].</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in
which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Voluntary Adjustment By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of
the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company unless such reduction would result in the Company violating any rules of its principal Trading Market.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof,
and the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender
this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. Subject to compliance with applicable securities laws, this Warrant may be divided or combined with other Warrants
upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations
in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to
any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges
shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company
is for any reason unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof,
shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other form.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALT5
    SIGMA CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
ALT5 SIGMA CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of lawful money of the United States.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 1in; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________    </FONT></TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; text-indent: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="text-align: justify; text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: _______________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_______________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>3
<FILENAME>ex4-6.htm
<DESCRIPTION>EX-4.6
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALT5
SIGMA CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 20,000,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: August 12, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, World Liberty Financial, Inc. or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;), to subscribe for and purchase from ALT5 Sigma Corporation, Inc., a Nevada
corporation (the &ldquo;<U>Company</U>&rdquo;), up to 20,000,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated August 11, 2025, among the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF or DocuSign copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per Warrant Share under this Warrant shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
8,000,000 shares of Common Stock at an exercise price of $7.50 per share of Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
4,000,000 shares of Common Stock at an exercise price of $8.25 per share of Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
4,000,000 shares of Common Stock at an exercise price of $9.00 per share of Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
4,000,000 shares of Common Stock at an exercise price of $9.75 per share of Common Stock, subject to adjustment hereunder (the
&ldquo;Exercise Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)=</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                            as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such
                                            Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
                                            and is delivered within two (2) hours thereafter (including until two (2) hours after the
                                            close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
                                            or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></TD>
</TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)=</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
     <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. For the avoidance of doubt, in the absence of an effective
registration statement registering the issuance of the Warrant Shares, or if Rule 144 is otherwise not available, the Company shall issue,
and the Holder agrees to receive, unregistered Warrant Shares upon a cashless exercise of this Warrant pursuant to this Section 2(c).
The Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market other than the OTCQB<SUP>&reg;</SUP> Venture Market or OTCQX<SUP>&reg;</SUP>, the bid price
of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)),
(b) if OTCQB or OTCQX is a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on OTCID&trade; (or an organization or agency succeeding to the functions of OTC Markets Group
Inc. of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market
value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest
of the Securities then outstanding and reasonably acceptable to the Company, the reasonable fees and expenses of which shall be paid
by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is a Trading Market, the
volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on
OTCID (or an organization or agency succeeding to the functions of OTC Markets Group Inc. of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the reasonable fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit and Withdrawal at Custodian (&ldquo;<U>DWAC</U>&rdquo;) service if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or the Holder rescinds such exercise. The Company agrees to maintain a transfer agent that
is a participant in the FAST Program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 noon (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver, or cause to be delivered,
the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise
Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than
in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely
due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker
to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Warrant Shares so purchased exceeds (y) the amount obtained by
multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at
issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver Warrant Shares upon exercise of the
Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached as Exhibit B hereto duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates, (ii) any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons whose beneficial
ownership of the shares of Common Stock would or could be aggregated with the Holder&rsquo;s for purposes of Section 13(d) (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and
Attribution Parties shall include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act. To the extent that the limitation contained in this Section 2(e) applies, the submission of a
Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99% / 9.99%]
(or, upon election by a Holder prior to the issuance of any Warrants, 4.99% / 9.99%]) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder, upon notice to
the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds [9.99]% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue
to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered
to the Company. If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of
Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares
of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the beneficial ownership of Holder
together with the Attribution Parties, as determined pursuant to this Section 2(e), to exceed the Beneficial Ownership Limitation, the
Holder shall then notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (such notice,
the &ldquo;<U>Reduction Notice</U>&rdquo;). Such issuance shall not be deemed to have occurred until the Holder provides the Reduction
Notice (or a notice that no reduction is needed) to the Company. In the event that the issuance of Common Stock to the Holder upon exercise
of this Warrant results in the Holder, together with the Attribution Parties, collectively being deemed to beneficially own, in the aggregate,
more than the Beneficial Ownership Limitation, the number of shares so issued by which the aggregate Beneficial Ownership of the Holder
and its Attribution Parties exceeds such limitation (the &ldquo;<U>Excess Shares</U>&rdquo;) shall be deemed null and void and shall
be cancelled ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares.
As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to
the Holder the exercise price paid by the Holder for the Excess Shares and the Holder shall return the Excess Shares to the Company.
The provisions of this paragraph shall not be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of Warrant Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of Warrant Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (excluding a merger effected
solely to change the Company&rsquo;s name), (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the assets of
the Company and its Subsidiaries, taken as a whole, in one or a series of related transactions, (iii) any, direct or indirect, purchase
offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding shares of the aggregate voting power of all classes of equity of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of the aggregate voting power of all classes of equity of the Company (not including any shares of Common Stock held by the other
Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share
purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise
of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant) (the &ldquo;<U>Fundamental Transaction Rights</U>&rdquo;), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
Warrant Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
Warrant Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to,
and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other
Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right
and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents
with the same effect as if such Successor Entity had been named as the Company herein; provided, however, that to the extent that the
Holder&rsquo;s right to participate in any such Fundamental Transaction Rights would result in the Holder and its Attribution Parties,
collectively, beneficially owning in excess of the Beneficial Ownership Limitation of the Common Stock that would be issued and outstanding
following receipt of such Fundamental Transaction Rights (such excess amount of Common Stock, the &ldquo;<U>Excess Fundamental Transaction
Rights</U>&rdquo;), then the Holder shall not be entitled to participate in such Fundamental Transaction Rights to the extent of the
Excess Fundamental Transaction Rights (and shall not have the right to acquire such Excess Fundamental Transaction Rights). The Excess
Fundamental Transaction Rights shall be held in abeyance for the benefit of the Holder until such time or times as (1) its right to receive
some or all of the Excess Fundamental Transaction Rights would not result in the Holder and its Attribution Parties beneficially owning
Common Stock in excess of the Beneficial Ownership Limitation and (2) the Holder so certifies in writing to the Company and specifies
the number of shares of Common Stock it is able to receive without exceeding the Beneficial Ownership Limitation, at which time or times
the Holder shall be granted that portion of the Excess Fundamental Transaction Rights (and any Excess Fundamental Transaction Rights
granted, issued or sold on such initial Fundamental Transaction Rights or on any subsequent Fundamental Transaction Rights to be held
similarly in abeyance) to the same extent as if there had been no such limitation. For the avoidance of doubt, the Holder shall be entitled
to the benefits of the provisions of this Section 3(d) regardless of whether the Company has sufficient authorized shares of Common
Stock for the issuance of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in
which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Voluntary Adjustment By Company</U>. The Company may at any time during the term of this Warrant, with the prior written consent of
the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company unless such reduction would result in the Company violating any rules of its principal Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof,
and the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any
registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. Subject to compliance with applicable securities laws, this Warrant may be divided or combined with other Warrants
upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations
in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to
any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges
shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event including if the Company
is for any reason unable to issue and deliver Warrant Shares upon exercise of the this Warrant as required pursuant to the terms hereof,
shall the Company be required to net cash settle an exercise of this Warrant or cash settle in any other form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock and
keep available a sufficient number of authorized but unissued shares to provide for the issuance of the Warrant Shares upon the exercise
of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under
this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALT5
    SIGMA CORPORATION</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Peter Tassiopoulos</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Lead Investor Warrant]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
ALT5 SIGMA CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2.5in">&nbsp;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: _______________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_______________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALT5
Sigma Corporation Announces Closing of </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$1.5
Billion Registered Direct Offering and Concurrent Private Placement to Initiate World Liberty Financial $WLFI Treasury Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Zach
                                            Witkoff, Co-Founder and CEO of World Liberty Financial, Inc., the company behind USD1, the
                                            fastest growing stablecoin in the world, becomes Chairman of the Board of Directors of ALT5;</I></B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eric
                                            Trump becomes a Director on its Board of Directors; </I></B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Zak
                                            Folkman, Co-Founder and COO of World Liberty Financial, becomes a Board Observer; and </I></B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Matt
                                            Morgan becomes its Chief Investment Officer</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ALT5
will continue its expansion as a leading provider of digital asset trading and payment solutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ALT5
will implement its $WLFI Treasury Strategy, holding approximately 7.5% of the total supply of $WLFI tokens</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAS
VEGAS, NEVADA - August 12, 2025 - </B>ALT5 Sigma Corporation (NASDAQ: ALTS)(FRA: 5AR1) (the &ldquo;Company&rdquo; or &ldquo;ALT5&rdquo;)
today announced the closing of a $1.5 billion registered direct offering (the &ldquo;Registered Direct Offering&rdquo;) and concurrent
private placement (the &ldquo;Private Placement Offering&rdquo; and, together with the Registered Direct Offering, the &ldquo;Offerings&rdquo;)
led by World Liberty Financial, Inc. (&ldquo;World Liberty Financial&rdquo;). The gross proceeds of the Offerings were approximately
$1.5 billion, before deducting placement agent fees and other offering expenses. The Offerings were priced at-the-market pursuant to
Nasdaq rules. Zach Witkoff, co-founder and CEO of World Liberty Financial became Chairman of the board of directors of the Company, Eric
Trump became a director on the Company&rsquo;s board of directors, Zak Folkman, co-founder and COO of World Liberty Financial, became
a board observer to the Company, and Matt Morgan became Chief Investment Officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">World
Liberty Financial acted as the lead investor in the concurrent private placement offering, and the Offerings included participation by
a select number of the world&rsquo;s largest institutional investors and prominent crypto venture capital firms. Kraken will serve as
the Asset Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P./Alliance
Global Partners acted as the sole placement agent in connection with the Offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered in the Registered Direct Offering (but excluding the securities offered in the Private Placement Offering) were offered
and sold by ALT5 pursuant to a &ldquo;shelf&rdquo; registration statement on Form S-3 (Registration No. 333-289176), including a base
prospectus, previously filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on August 1, 2025 and declared effective
by the SEC on August 8, 2025. The offering of the securities to be issued in the Registered Direct Offering were being made only by means
of a prospectus supplement that forms a part of the registration statement. A final prospectus supplement and an accompanying base prospectus
relating to the Registered Direct Offering was filed with the SEC on August 11, 2025, and is available on the SEC&rsquo;s website located
at http://www.sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offer and sale of the securities in the Private Placement Offering described above were being made in transactions not involving a public
offering and have not been registered pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
and/or Rule 506(b) of Regulation D promulgated thereunder and have not been registered under the Securities Act or applicable state securities
laws. Accordingly, the securities in the Private Placement Offering may not be reoffered or resold in the United States except pursuant
to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable
state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP acted as legal advisor to A.G.P./Alliance Global Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSF
Kramer LLP acted as special counsel to A.G.P./Alliance Global Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP and Clark Hill PLC acted as legal advisors to ALT5 Sigma Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ALT5 Sigma</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT5
Sigma Corporation (NASDAQ: ALTS)(FRA:5AR1) is a fintech, providing next generation blockchain-powered technologies for tokenization,
trading, clearing settlement, payment and safe keeping of digital assets. Since June of 2025, the Company has been a member of the Russell
Microcap Growth<SUP>&reg;</SUP>, Russell 3000E<SUP>&reg;</SUP>, and Russell 3000E Growth<SUP>&reg;</SUP> Indexes, as part of the 2025
Russell indexes reconstitution. The Company had previously been included in the Russell Microcap<SUP>&reg;</SUP> Index since June of
2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded
in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation), provides next-generation blockchain-powered technologies
to enable a migration to a new global financial paradigm. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms to its
customers: &ldquo;ALT5 Pay&rdquo; and &ldquo;ALT5 Prime.&rdquo; ALT5 Sigma has processed over $5 billion USD in cryptocurrency transactions
since inception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT5
Pay is an award-winning cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency
payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or
ALT5 Pay&rsquo;s checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their
payment in digital assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT5
Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets.
Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through
a browser-based access mobile phone application named &ldquo;ALT5 Pro&rdquo; that can be downloaded from the Apple App Store, from Google
Play, through ALT5 Prime&rsquo;s FIX API, as well as through Broadridge Financial Solutions&rsquo; NYFIX gateway for approved customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is working on the potential separation of its biotech business that will move forward under &ldquo;Alyea Therapeutics Corporation.&rdquo;
Through its biotech activities, the Company is focused on bringing to market drugs with non-addictive pain-relieving properties to treat
conditions that cause chronic or severe pain. The Company&rsquo;s patented product, a novel formulation of low-dose naltrexone (JAN123),
is being initially developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain
generally affecting the arms or legs. The FDA has granted JAN123 Orphan Drug Designation for treatment of CRPS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is expected to adopt a $WLFI Treasury Strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
World Liberty Financial</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">World
Liberty Financial (WLFI) is a pioneering decentralized finance (DeFi) protocol and governance platform dedicated to empowering individuals
through transparent, accessible, and secure financial solutions. Inspired by the vision of President Donald J. Trump, WLFI seeks to democratize
access to DeFi by creating user-friendly tools that bring the benefits of decentralized finance to a broader audience. WLFI plans to
be at the forefront of DeFi, offering an intuitive, robust platform that empowers users to participate actively in the financial future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act
of 1995, including, but not limited to, statements relating to the expected use of proceeds from the Offerings, the Company&rsquo;s expectation
to initiate its $WLFI Treasury Strategy, the profitability and prospective growth of ALT5&rsquo;s platforms and business that may include,
but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5&rsquo;s
services, and technology challenges for future growth or expansion, and statements regarding the Company&rsquo;s potential separation
plans of its biotech business. This press release also contains general statements relating to risks that the Company&rsquo;s potential
separation plans of its biotech business and the potential for JAN123 to treat CRPS, and other statements, including words such as &ldquo;continue&rdquo;,
&ldquo;expect&rdquo;, &ldquo;intend&rdquo;, &ldquo;will&rdquo;, &ldquo;hope&rdquo;, &ldquo;should&rdquo;, &ldquo;would&rdquo;, &ldquo;may&rdquo;,
&ldquo;potential&rdquo;, and other similar expressions. Such statements reflect the Company&rsquo;s current view with respect to future
events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered
reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties,
and contingencies. This press release also contains statements that are forward-looking in respect of the expected future partial or
full disposition of the Company&rsquo;s interests in Alyea without specificity of the scope or methods thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
factors could cause the Company&rsquo;s actual results, performance, or achievements to be materially different from any future results,
performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company&rsquo;s
periodic reports filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Should one or more of these risks or uncertainties
materialize, or should the assumptions set out in the section entitled &ldquo;Risk Factors&rdquo; in the Company&rsquo;s filings with
the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein.
These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any
obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will
prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals
are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to
put undue reliance on forward-looking statements due to the inherent uncertainty therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact for ALT5 Sigma Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ALT5@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>203-682-8284</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact for ALT5 Sigma Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ALT5@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact for World Liberty Financial</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
Wachsman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>david@wachsman.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, *8# 2(  A$! Q$!_\0
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0/++$O"[CCYCZGW]Z* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>alts-20250812.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCO+bP9z5Z8mekhvWB0bWk6fyQsYJLfby6917HGsVUJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ALTS="http://alt5sigma.com/20250812" elementFormDefault="qualified" targetNamespace="http://alt5sigma.com/20250812">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://alt5sigma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="alts-20250812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="alts-20250812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>alts-20250812_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>alts-20250812_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="alts-20250812.xsd#Cover" roleURI="http://alt5sigma.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://alt5sigma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALT5
SIGMA CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000862861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1454591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">325
    E. Warm Spring Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las Vegas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">997-5968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock (par value $0.001 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ALTS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alt5sigma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>alts-20250812.xsd</File>
    <File>alts-20250812_lab.xml</File>
    <File>alts-20250812_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "ALTS",
   "nsuri": "http://alt5sigma.com/20250812",
   "dts": {
    "schema": {
     "local": [
      "alts-20250812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "alts-20250812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "alts-20250812_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://alt5sigma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001641172-25-024661-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-024661-xbrl.zip
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M.4[_G3QWGHC;Q5[PL!JV0M)2AH>*S5X?,&4,$D$^3JPK7.4-#>NK9%JYNU>
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MO1[0E;'[$TW*/KAJ "ULJF#&J3>[2S=JNWTK2VUC]F.AW/2D[ N7\5[SW,5
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M$AWK2'7WS$WE:9JZ4E^0FMV*0TN_S@Z0L4+>V9M*1R0^M39H:]UU I(_##?
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MJN(NNV(4Z%[MI=+&KAG"CVIE^CBG9E9BM3\@S+:J8.V5S%COV+:4EVB]QV5
M@8G'1"I5D9&O@5M98>U0^.T5[T&75L-O>?4M5K= M'TN4:3NPZ 5W,-BAR+Y
MEIAIJ>ZH"D:T)7(V^)+'DZQ;:,K<7V7CL9:>"56;!B&6X,-.,Z8=9F1J%'40
MHDXSZZX6_LW*3+J!^(<"*+@C7/7?-[CJ#:[Z'I:8?)B7_$[;8O[W<5(EY442
M_\\&*/8(CGS*0+$]TQ%-X/-#<I^;3VUK7.L17I=W54DK04E?!Q.)/MN?[?P(
M_ 0Q7%-5U:BU=5,SL.4.O&972:=/6D?Y)@;]1A+,0 >-I>&RLW_6"!K^F5(*
M[?/8W+9'<-O.^+8=ZGY#K-7?M\)&#_S\=[:?W14!2$]T4]0*B< -1#/[_70.
M]MR%[E/A1*K1V%<Q>;^*FZDSW,$S=4%8YG'88W".D+7V0-IX&4RC"=F[Y S
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M"UDESBUAX40?AQI!8' "V%,O3L98?8F#YISWF&"!V#J'<2!Y_)B>^#L!$ E
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MV;@.)\+Y78U/$ZZ2M7YL#47*)RW2MD&P%EE6M"T"C@G=[[53DKO95!N;AU9
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M95;=:E,XI#D#30BMTM_>;,-$]\G':"33(4?4L7:<3]<!9>_DJ(*B=*P;\'>
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M5OU2P"71PVZ%,%E3"V2YLVD1FA=8)9A3C]8PE_H5;.!_VFWD/2J)]X$JA^H
M$_Q2*(!-/"C:[="_>'A\]F-)QD*WR?,L/T!Z;*%_U6>OH2,W8B?CRK2.J1_E
M<[IBPFR121*9.5!2_E0=)<T:9N;K;;,CLR4'84M;\F;'17?KFG/+86R-5R67
M#L3U-,/Z72O[.CH0%W &GI,7AMBW4W]HJWR*OKE[1'.X!2XO87C?*GG3]L6@
M?41XDE*] ^@Y;_UR7CZL7_7NQKG9ZT01L5[2CUZ?'P_YUR/M".LJY^"A$D4
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MT6R\U9$UD<S$&VLF^>BP]_[RU5-@<$B:?FR5(\7>]O;VR=VOB<JY(2LF$F<
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M*N_>W4(@)L# ]_=O53 [&4$S.1]?M%K>1[ ['W^#J7CS7,%_Q+>0X;.U+!!
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M1NHM^C<-_3]R2/\6XO\#4$L#!!0    ( )2*$ELU+1+V$BD  *=" 0 +
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MX<!3THZH:]NY1;U)2/B^O,/%!*PWS ['>3](7L>UH&!O0%^H8427-(R"&F!
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M+3(P,C4P.#$R+GAS9%!+ 0(4 Q0    ( )2*$EOP]-E6_0H  '^&   5
M          "  5H#  !A;'1S+3(P,C4P.#$R7VQA8BYX;6Q02P$"% ,4
M" "4BA);KH\X"UD'  #65P  %0              @ &*#@  86QT<RTR,#(U
M,#@Q,E]P<F4N>&UL4$L! A0#%     @ E(H26U#.L99V1P  =L8!  D
M         ( !%A8  &5X-"TR+FAT;5!+ 0(4 Q0    ( )2*$EN'I517>4@
M )O* 0 )              "  ;-=  !E>#0M-BYH=&U02P$"% ,4    " "4
MBA); *U11)P4   2<0  "@              @ %3I@  97@Y.2TQ+FAT;5!+
M 0(4 Q0    ( )2*$ELU+1+V$BD  *=" 0 +              "  1>[  !F
@;W)M."UK+FAT;5!+!08     !P ' *0!  !2Y      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="alts-20250812.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-12" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-12" id="Fact000004">0000862861</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-12" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-12" id="Fact000010">2025-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-12" id="Fact000011">ALT5 SIGMA CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-12" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-12" id="Fact000013">000-19621</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-12" id="Fact000014">41-1454591</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-12" id="Fact000015">325     E. Warm Spring Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-08-12" id="Fact000016">Suite 102</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-12" id="Fact000017">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-12" id="Fact000018">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-12" id="Fact000019">89119</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-12" id="Fact000020">(702)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-12" id="Fact000021">997-5968</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-12" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-12" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-12" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-12" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-08-12" id="Fact000026">Common     stock (par value $0.001 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-12" id="Fact000027">ALTS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-12" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-12" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
